The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome

To gain further knowledge on the preclinical phase of Alzheimer’s disease (AD), we sought to characterize cognitive performance, neuroimaging and plasma-based AD biomarkers in a cohort of non-demented adults with down syndrome (DS). The goal of the down syndrome biomarker Initiative (DSBI) pilot is...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Behav Neurosci
Autori principali: Rafii, Michael S., Wishnek, Hannah, Brewer, James B., Donohue, Michael C., Ness, Seth, Mobley, William C., Aisen, Paul S., Rissman, Robert A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2015
Soggetti:
Neuroscience
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4568340/
https://ncbi.nlm.nih.gov/pubmed/26441570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnbeh.2015.00239
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi